Trials / Completed
CompletedNCT03469167
Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding
Clinical Study to Evaluate Efficacy and Safety of "CEGP003(Wound Dressing Solution Containing EGF)" for Achieving Hemostasis and Protecting Ulcer in Patients With Acute Peptic Ulcer Bleeding: A Prospective, Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- CGBio Inc. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, single-blinded, randomized study to evaluate the efficacy and safety of CEGP003 in patients with acute peptic ulcers bleeding, compared to endoscopic epinephrine injection therapy.
Detailed description
CEGP003 is wound dressing solution containing Hydroxyethyl-cellulose and EGF. Epidermal growth factor (EGF) stimulates cell growth and differentiation by binding to its receptor, which can enhance wound healing and regeneration of new tissue, finally may provide a new option in treating a peptic ulcers bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CEGP003 | Application of CEGP003 to peptic ulcer bleeding |
| DEVICE | Injection Tx | Injection of epinephrine to peptic ulcer bleeding |
Timeline
- Start date
- 2014-10-15
- Primary completion
- 2015-11-10
- Completion
- 2017-01-02
- First posted
- 2018-03-19
- Last updated
- 2018-03-19
Source: ClinicalTrials.gov record NCT03469167. Inclusion in this directory is not an endorsement.